RGNX REGENXBIO Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
09:20
Jan 24
Jan 24
r/biotech_stocks
Long RGNX ahead of PDUFA with 89% ML score.
The author's ML model holds RGNX long ahead of a PDUFA catalyst in 15 days, assigning an 89% confidence score for a positive catalyst outcome. A favorable FDA decision could move the stock toward the $17.02 target; the trade is invalidated below the $13.02 stop loss.
RGNX
REGENXBIO Inc.
Long
1ST
—
—
22:23
Jan 01
Jan 01
r/biotech_stocks
Long RGNX on PDUFA and DMD catalysts
Author expects REGENXBIO shares to rise 50% by end of year. The Hunter syndrome PDUFA date is February 8, and the FDA delay was due to new longer-term data that the author says results were great. Approval would include a priority review voucher, which the author notes last sold for $160 million. Additionally, pivotal DMD results are expected in Q1 with a filing in mid-2026.
RGNX
REGENXBIO Inc.
Long
1ST
—
—
About RGNX Investor Commentary
Across the available history and selected sources, Buzzberg tracks RGNX (REGENXBIO Inc.) across 5 sources: 2 bullish vs 0 bearish calls from 6 authors. Historical directional balance: 22% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 9 total trade ideas tracked. Latest voices: u/DrinkConscious9173, u/fbksminer.